Takeda Joins YuanBio in Drug Discovery
23 Jan 2025
US$ 19.00
Takeda Ventures Inc, the corporate venture unit of Takeda Pharmaceutical Co Ltd, and YuanBio Venture Capital ......
Related Publications
HongShan Capital Group and GL Ventures have separately led the pre-series A and pre-series A+ funding rounds of ......
Kamet Capital, a Singapore-headquartered multi-single-family office, has invested US$8.5 m in the series A funding ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.